Displaying 26–50 of 11090 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...444

GSK starts late-stage study for new-age antibiotic

(News)

GlaxoSmithKline has begun a late-stage study testing its experimental antibiotic, gepotidacin, in patients with urinary tract infections and gonorrhoea.

Mirum grabs breakthrough designation for liver drug

(News)

Mirum Pharmaceuticals announced that the U.S. FDA has granted Breakthrough Therapy Designation for maralixibat for the treatment of pruritus associated with Alagille syndrome

Allergan's Botox gets pediatric approval

(News)

Allergan announced that the U.S. FDA has approved the company's supplemental Biologics License Application for Botox for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy.

Pharma in review: trending stories 10/25/19

(News)

pharma manufacturing news in review

Vertex, NHS England finally agree on Orkambi price

(News)

The National Health Service (NHS) in England has finally approved Vertex's Orkambi to treat people with cystic fibrosis, after four years of deadlock over the price tag.

eBook: Pharma Innovation 2019

(Whitepaper)

Amgen makes major price cut to Repatha

(News)

Amgen announced this week that it has slashed the price of its cholesterol med, Repatha, by 60 percent.

Getting safety stock just right

(Article)

Preventing drug shortages with cognitive automation

Pharma: Reluctant revolutionaries

(Article)

Pharma needs to rally behind digital if it wants to see real change

Irish Novartis workers ‘shocked’ by layoff announcement

(News)

About 320 workers at a Novartis plant in Ringaskiddy, Ireland found out this week that their jobs are going to be cut.

Biogen announces surprise submission for Alzheimer’s drug approval

(News)

Biogen said it is now resurrecting its hope that the drug could become a blockbuster, and will seek FDA approval for the medication early next year.

Takeda acquires Cour celiac disease treatment for up to $420 million

(News)

The Japanese company has bought the exclusive global license to an immune modifying nanoparticle designed to induce tolerance to gluten in patients with celiac disease.

Vertex wins FDA approval for cystic fibrosis combo treatment

(News)

The pharma company has also priced the three-drug combination at more than $300,000 per year.

How automating your pharma packaging process reduces risk

(Article)

Each manual step in the process introduces the potential for errors, a fear for every pharma and medical device company.

Drug companies avert landmark opioid trial with last-minute deal

(News)

At the last minute, four of the companies reached a deal totaling $260 million and avoided heading to court.

J&J asbestos-related baby powder recall woes continue

(News)

J&J said it was recalling a single lot of its Johnson’s Baby Powder, “out of an abundance of caution,” after a U.S. FDA test found “sub-trace levels” of chrysotile asbestos in one bottle.

Sanofi in talks to sell surgical unit to Baxter

(News)

Sanofi is in advanced talks to sell its Seprafilm surgical products unit to U.S. medical supply company, Baxter International, according to Bloomberg sources.

Finalists announced for CPhI Worldwide Awards

(News)

CPhI Worldwide has revealed the finalists for the annual CPhI Pharma Awards.

Merck to lay off 500

(News)

Merck said it plans to eliminate approximately 500 jobs largely based out of Pennsylvania along with a small number of New Jersey positions.

Pharma in review: trending stories 10/18/19

(News)

pharma manufacturing news in review

VIDEO: Pharma careers and salaries

(Article)

VIDEO: Pharma career and salary survey results

From run-to-failure maintenance to predictive maintenance: A case study

(Article)

DATA MANAGEMENT: How one company used IIoT to go from a run-to-failure mentality to proactively preventing breakdowns.

FDA calls out Torrent as key contributor to major recall

(News)

The FDA has issued a warning letter to Torrent Pharmaceuticals and said the company is at the center of its investigation into a global recall of several blood pressure medications.

Report: Teva may donate $15B in generic drugs to resolve opioid lawsuits

(News)

With several major pharma companies staring down the start of a federal trial related to opioids, Teva Pharmaceuticals is reportedly looking to settle by donating $15 billion in drugs.

Sort By Relevance Sort By Date
1 2 3 4 5 ...444